Bio-Rad Laboratories, Inc.
BIOB
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.62B | 1.56B | 1.54B | 1.42B | 1.37B |
| Total Receivables | 450.70M | 439.50M | 472.50M | 474.20M | 478.00M |
| Inventory | 780.60M | 770.50M | 740.70M | 783.20M | 798.80M |
| Prepaid Expenses | 147.80M | 150.00M | 136.50M | 152.00M | 149.60M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 22.90M | 17.40M | 15.80M | 14.00M | 10.90M |
| Total Current Assets | 3.02B | 2.94B | 2.91B | 2.84B | 2.81B |
|
|
|||||
| Total Current Assets | 3.02B | 2.94B | 2.91B | 2.84B | 2.81B |
| Net Property, Plant & Equipment | 671.90M | 689.40M | 709.90M | 720.50M | 740.10M |
| Long-term Investments | 574.30M | 577.10M | 579.80M | 578.70M | 581.60M |
| Goodwill | 574.30M | 577.10M | 579.80M | 578.70M | 581.60M |
| Total Other Intangibles | 160.00M | 166.80M | 174.30M | 388.40M | 396.90M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 102.70M | 103.90M | 103.80M | 110.20M | 109.20M |
| Total Assets | 10.25B | 9.79B | 10.58B | 9.70B | 10.21B |
|
|
|||||
| Total Accounts Payable | 143.50M | 133.10M | 129.00M | 128.80M | 139.30M |
| Total Accrued Expenses | 150.50M | 148.40M | 172.30M | 182.80M | 157.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 434.30M | 436.70M | 37.40M | 38.10M | 40.60M |
| Total Finance Division Other Current Liabilities | 233.00M | 198.80M | 178.30M | 172.60M | 211.20M |
| Total Other Current Liabilities | 233.00M | 198.80M | 178.30M | 172.60M | 211.20M |
| Total Current Liabilities | 961.30M | 917.00M | 517.00M | 522.30M | 548.90M |
|
|
|||||
| Total Current Liabilities | 961.30M | 917.00M | 517.00M | 522.30M | 548.90M |
| Long-Term Debt | 794.60M | 794.30M | 1.19B | 1.19B | 1.19B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 141.50M | 147.20M | 154.40M | 164.60M | 173.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.18B | 1.08B | 1.26B | 1.08B | 1.17B |
| Total Liabilities | 3.08B | 2.94B | 3.12B | 2.96B | 3.09B |
|
|
|||||
| Common Stock & APIC | 502.90M | 490.50M | 476.00M | 461.90M | 484.60M |
| Retained Earnings | 8.02B | 7.65B | 8.18B | 7.46B | 7.80B |
| Treasury Stock & Other | -1.35B | -1.29B | -1.20B | -1.18B | -1.15B |
| Total Common Equity | 7.17B | 6.85B | 7.45B | 6.74B | 7.13B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.17B | 6.85B | 7.45B | 6.74B | 7.13B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.17B | 6.85B | 7.45B | 6.74B | 7.13B |
|
|
|||||